ent-4-(4-methylphenyl)-2-oxo-8-propyl-1,2,5,6,7,8-hexahydro-1,6-naphthyridine-3-carbonitrile hydrochloride

ID: ALA5200395

Chembl Id: CHEMBL5200395

PubChem CID: 168290566

Max Phase: Preclinical

Molecular Formula: C19H22ClN3O

Molecular Weight: 307.40

Associated Items:

Names and Identifiers

Canonical SMILES:  CCCC1CNCc2c1[nH]c(=O)c(C#N)c2-c1ccc(C)cc1.Cl

Standard InChI:  InChI=1S/C19H21N3O.ClH/c1-3-4-14-10-21-11-16-17(13-7-5-12(2)6-8-13)15(9-20)19(23)22-18(14)16;/h5-8,14,21H,3-4,10-11H2,1-2H3,(H,22,23);1H

Standard InChI Key:  IBIVNJVPIOCNDX-UHFFFAOYSA-N

Associated Targets(Human)

PDE9A Tchem Phosphodiesterase 9A (1131 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PDE2A Tclin Phosphodiesterase 2A (1799 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PDE5A Tclin Phosphodiesterase 5A (5113 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PDE7B Tclin Phosphodiesterase 7B (96 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PDE8A Tclin Phosphodiesterase 8A (260 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PDE10A Tclin Phosphodiesterase 10A (5542 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PDE11A Tchem Phosphodiesterase 11A (449 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PDE3B Tclin Phosphodiesterase 3B (312 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PDE4B Tclin Phosphodiesterase 4B (2748 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 307.40Molecular Weight (Monoisotopic): 307.1685AlogP: 3.21#Rotatable Bonds: 3
Polar Surface Area: 68.68Molecular Species: BASEHBA: 3HBD: 2
#RO5 Violations: HBA (Lipinski): 4HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: 7.12CX Basic pKa: 9.57CX LogP: 1.15CX LogD: 1.02
Aromatic Rings: 2Heavy Atoms: 23QED Weighted: 0.91Np Likeness Score: -0.25

References

1. Meibom D, Micus S, Andreevski AL, Anlauf S, Bogner P, von Buehler CJ, Dieskau AP, Dreher J, Eitner F, Fliegner D, Follmann M, Gericke KM, Maassen S, Meyer J, Schlemmer KH, Steuber H, Tersteegen A, Wunder F..  (2022)  BAY-7081: A Potent, Selective, and Orally Bioavailable Cyanopyridone-Based PDE9A Inhibitor.,  65  (24.0): [PMID:36475653] [10.1021/acs.jmedchem.2c01267]

Source